Company Filing History:
3 out of 42 
1 out of 1 Years Active: 2003-2010
Title: The Innovative Contributions of Jean-Marc Zuccarelli
Introduction
Jean-Marc Zuccarelli is a notable inventor based in Antibes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of fast disintegrating tablets. With a total of four patents to his name, his work has the potential to enhance patient compliance and improve medication delivery.
Latest Patents
One of Jean-Marc Zuccarelli's latest patents is for a fast disintegrating tablet. This invention focuses on an improved multiparticulate tablet that disintegrates in the mouth upon contact with saliva in less than 40 seconds. The invention is characterized by its use of particles of coated active principles, which possess intrinsic compression properties. The formulation includes a mixture of carriers, with the proportion of the carrier mixture relative to the coated active principle particles being between 0.4 to 6 parts by weight. The carrier mixture consists of a disintegrating agent, a diluting soluble agent with binding properties, a lubricant, and a permeabilizing agent. Additionally, the formulation may include sweeteners, flavoring, and coloring agents, with specific proportions for the disintegrating agent and soluble agent relative to the tablet mass.
Career Highlights
Throughout his career, Jean-Marc Zuccarelli has worked with reputable companies in the pharmaceutical industry. Notable among these are Ethypharm, Inc. and Laboratoires des Produits Ethiques Ethypharm SA. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Jean-Marc has collaborated with several professionals in his field, including Charles Chauveau and Nourredine Nouri. These collaborations have likely enriched his work and contributed to the success of his inventions.
Conclusion
Jean-Marc Zuccarelli's innovative work in the development of fast disintegrating tablets showcases his commitment to improving pharmaceutical formulations. His contributions are significant in enhancing the efficiency of medication delivery systems.